• Cormorant Asset Management reported a sale of 425,000 Corbus Pharmaceuticals common shares on Oct. 29, 2026.
• The reported sale price was $4.1006 per share, leaving indirect beneficial ownership of 1,919,971 shares.
• The Nov. 2, 2026, filing lists managing member Bihua Chen and the Cormorant reporting entities as former 10% owners.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Corbus Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000929638-26-004182), on November 02, 2026, and is solely responsible for the information contained therein.